Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
12
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Pavao Mark H | Director | 1 | $0 | $0 | 2026-04-09 |
| Swaminathan Arun | Chief Executive Officer | 4 | $73.5K | $0 | 2026-01-22 |
| Grossman Fred | Chief Medical Officer | 7 | $20.0K | $0 | 2026-01-22 |
| Berman Howard | Executive Chairman | 7 | $0 | $0 | 2026-01-22 |
| SNYDER DAVID S | Chief Financial Officer | 8 | $12.9K | $0 | 2026-01-22 |
| Lee Ann | Director | 9 | $3.6K | $0 | 2026-01-02 |
| Villalobos Anabella | Director | 6 | $0 | $0 | 2026-01-02 |
| Weinand Dieter | Director | 5 | $0 | $0 | 2026-01-02 |
| GOLDSTEIN DOV A MD | Director | 8 | $0 | $0 | 2026-01-02 |
| ROSS WILBUR L JR | Director | 4 | $0 | $0 | 2026-01-02 |
| Garren Hideki | Director | 3 | $0 | $0 | 2024-01-01 |
| Hepner Adrian | Chief Medical Officer | 3 | $0 | $0 | 2023-02-27 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Pavao Mark H | Director | A Award deriv | 2026-04-09 | 2026-04-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Swaminathan Arun | Chief Executive Officer | A Award deriv | 2026-01-22 | 2026-01-26 | 293,983 | — | $0 | 293,983 | SEC↗ |
| Berman Howard | Executive Chairman | A Award deriv | 2026-01-22 | 2026-01-26 | 15,257 | — | $0 | 15,257 | SEC↗ |
| Grossman Fred | Chief Medical Officer | A Award deriv | 2026-01-22 | 2026-01-26 | 140,041 | — | $0 | 140,041 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | A Award deriv | 2026-01-22 | 2026-01-26 | 140,041 | — | $0 | 140,041 | SEC↗ |
| Lee Ann | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ROSS WILBUR L JR | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Weinand Dieter | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Villalobos Anabella | Director | A Award deriv | 2026-01-02 | 2026-01-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise deriv | 2025-08-18 | 2025-08-19 | 17,557 | — | $0 | 0 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | M Exercise | 2025-08-18 | 2025-08-19 | 17,557 | $1.09 | $19.1K | 27,557 | SEC↗ |
| ROSS WILBUR L JR | Director | A Award deriv | 2025-02-25 | 2025-02-25 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Weinand Dieter | Director | A Award deriv | 2025-02-25 | 2025-02-25 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2025-02-25 | 2025-02-25 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Villalobos Anabella | Director | A Award deriv | 2025-02-25 | 2025-02-25 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Lee Ann | Director | A Award deriv | 2025-02-25 | 2025-02-25 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Berman Howard | Director | A Award deriv | 2025-01-09 | 2025-01-13 | 150,602 | — | $0 | 150,602 | SEC↗ |
| Grossman Fred | Chief Medical Officer | A Award deriv | 2025-01-09 | 2025-01-13 | 140,562 | — | $0 | 140,562 | SEC↗ |
| Swaminathan Arun | Chief Executive Officer | A Award deriv | 2025-01-09 | 2025-01-13 | 240,964 | — | $0 | 240,964 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | A Award deriv | 2025-01-09 | 2025-01-13 | 140,562 | — | $0 | 140,562 | SEC↗ |
| Weinand Dieter | Director | A Award deriv | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Villalobos Anabella | Director | A Award deriv | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Lee Ann | Director | A Award deriv | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ROSS WILBUR L JR | Director | A Award deriv | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2025-01-01 | 2025-01-03 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | P Buy | 2024-11-14 | 2024-11-14 | 1,800 | $7.19 | $12.9K | 8,800 | SEC↗ |
| Swaminathan Arun | Chief Executive Officer | P Buy | 2024-11-13 | 2024-11-13 | 5,000 | $7.36 | $36.8K | 10,000 | SEC↗ |
| Swaminathan Arun | Chief Executive Officer | P Buy | 2024-11-11 | 2024-11-12 | 5,000 | $7.34 | $36.7K | 5,000 | SEC↗ |
| Grossman Fred | Chief Medical Officer | P Buy | 2024-11-11 | 2024-11-12 | 2,710 | $7.37 | $20.0K | 2,710 | SEC↗ |
| Grossman Fred | Chief Medical Officer | A Award deriv | 2024-06-03 | 2024-06-05 | 70,596 | — | $0 | 70,596 | SEC↗ |
| Berman Howard | Chief Executive Officer | A Award deriv | 2024-06-03 | 2024-06-05 | 163,663 | — | $0 | 163,663 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | A Award deriv | 2024-06-03 | 2024-06-05 | 70,596 | — | $0 | 70,596 | SEC↗ |
| Grossman Fred | Chief Medical Officer | A Award deriv | 2024-01-31 | 2024-02-02 | 81,819 | — | $0 | 81,819 | SEC↗ |
| Grossman Fred | Chief Medical Officer | A Award deriv | 2024-01-31 | 2024-02-02 | 74,069 | — | $0 | 74,069 | SEC↗ |
| Berman Howard | Chief Executive Officer | A Award deriv | 2024-01-31 | 2024-02-02 | 189,680 | — | $0 | 189,680 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | A Award deriv | 2024-01-31 | 2024-02-02 | 81,819 | — | $0 | 81,819 | SEC↗ |
| ROSS WILBUR L JR | Director | A Award deriv | 2024-01-02 | 2024-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Villalobos Anabella | Director | A Award deriv | 2024-01-01 | 2024-01-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Weinand Dieter | Director | A Award deriv | 2024-01-01 | 2024-01-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Lee Ann | Director | A Award deriv | 2024-01-01 | 2024-01-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Garren Hideki | Director | A Award deriv | 2024-01-01 | 2024-01-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | A Award deriv | 2024-01-01 | 2024-01-19 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Lee Ann | Director | P Buy | 2023-08-22 | 2024-03-05 | 1,000 | $3.62 | $3.6K | 17,479 | SEC↗ |
| Weinand Dieter | Director | A Award deriv | 2023-08-18 | 2023-08-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Grossman Fred | Chief Medical Officer | A Award deriv | 2023-07-17 | 2023-07-19 | 74,069 | — | $0 | 74,069 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | A Award deriv | 2023-02-27 | 2023-03-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Hepner Adrian | Chief Medical Officer | A Award deriv | 2023-02-27 | 2023-03-01 | 115,000 | — | $0 | 115,000 | SEC↗ |
| Berman Howard | Chief Executive Officer | A Award deriv | 2023-02-27 | 2023-03-01 | 165,000 | — | $0 | 165,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | P Buy deriv | 2023-01-03 | 2023-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Villalobos Anabella | Director | P Buy deriv | 2023-01-03 | 2023-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | P Buy deriv | 2023-01-03 | 2023-01-04 | 3,500 | — | $0 | 3,500 | SEC↗ |
| Garren Hideki | Director | P Buy deriv | 2023-01-03 | 2023-01-04 | 1,000 | — | $0 | 1,000 | SEC↗ |
| Hepner Adrian | Chief Medical Officer | P Buy deriv | 2023-01-03 | 2023-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| Lee Ann | Director | P Buy deriv | 2023-01-03 | 2023-01-04 | 5,000 | — | $0 | 9,479 | SEC↗ |
| Lee Ann | Director | C Conversion deriv | 2023-01-03 | 2023-01-04 | 0 | — | $0 | 6,479 | SEC↗ |
| Berman Howard | Chief Executive Officer | P Buy deriv | 2023-01-03 | 2023-01-04 | 5,000 | — | $0 | 5,000 | SEC↗ |
| GOLDSTEIN DOV A MD | Director | P Buy | 2023-01-03 | 2023-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Villalobos Anabella | Director | P Buy | 2023-01-03 | 2023-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| SNYDER DAVID S | Chief Financial Officer | P Buy | 2023-01-03 | 2023-01-04 | 7,000 | — | $0 | 7,000 | SEC↗ |
| Garren Hideki | Director | P Buy | 2023-01-03 | 2023-01-04 | 2,000 | — | $0 | 2,000 | SEC↗ |
| Hepner Adrian | Chief Medical Officer | P Buy | 2023-01-03 | 2023-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Lee Ann | Director | C Conversion | 2023-01-03 | 2023-01-04 | 6,479 | $4.00 | $25.9K | 16,479 | SEC↗ |
| Lee Ann | Director | P Buy | 2023-01-03 | 2023-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |
| Berman Howard | Chief Executive Officer | P Buy | 2023-01-03 | 2023-01-04 | 10,000 | — | $0 | 10,000 | SEC↗ |